when was velcade approved in us
In May 2003, the FDA approved Velcade for the treatment of relapsed/refractory myeloma. It was approved in 2005 for patients with relapsed myeloma and in June 2008 for previously untreated myeloma patients. Today, Velcade is approved for use in myeloma in over 85 countries.